sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
31-Oct-2014 22:03
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 426-450 out of 913.

<< < 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 > >>

Public Release: 5-Dec-2013
Cell
NIH-funded scientists describe how mosquitoes are attracted to humans
Scientists at the University of California, Riverside have shown that certain mosquito nerve cells, known as cpA neurons, cause mosquitoes to be attracted to humans by detecting exhaled carbon dioxide and odors emitted from human skin. Their findings, published Dec. 5 in the journal Cell, may have implications for the control of mosquitoes and the diseases they transmit. The study was supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Nalini Padmanabhan
padmanabhannm@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 5-Dec-2013
Rise in R&D funding could set stage for malaria eradication by providing new tools
A new analysis of funding trends in the global battle against malaria reveals that, over the last two decades, there has been a five-fold increase in annual funding for malaria research and development--from US$131 million in 1993 to $610 million in 2011. Much of that increase took place after 2004, when support stood at $320 million.

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
PATH Malaria Vaccine Initiative

Public Release: 5-Dec-2013
Cell
How mosquitoes are drawn to human skin and breath
Scientists at the University of California, Riverside have found that the very receptors in the mosquito's maxillary palp that detect carbon dioxide are ones that detect skin odors as well, thus explaining why mosquitoes are attracted to skin odor -- smelly socks, worn clothes, bedding -- even in the absence of carbon dioxide. Using a chemical computational method they developed, the researchers identified affordable, safe and pleasant-smelling compounds that could find use in mosquito control.
NIH/National Institute of Allergy and Infectious Diseases, National Science Foundation, University of California Global Health Institute, Bill and Melinda Gates Foundation

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 5-Dec-2013
Cell
New insights into how human skin attracts mosquitoes could lead to better repellants and traps
Every time a mosquito is lured to the scent of your skin, you're at risk of contracting malaria, dengue fever, West Nile virus, or another deadly disease. A new study reveals an important class of neurons responsible for a mosquito's attraction to human skin odor, as well as odors that stimulate and inhibit the activity of these neurons. The findings could lead to a new generation of repellants and traps for effective mosquito control worldwide.

Contact: Mary Beth O'Leary
moleary@cell.com
617-397-2802
Cell Press

Public Release: 4-Dec-2013
Research & development for diseases of the poor: A 10-year analysis of impact of the DNDi model
Today, at a scientific meeting at Institut Pasteur, France, entitled 'Best Science for the Most Neglected: Where Do We Stand Ten Years On?', co-organized with Institut Pasteur and MSF and in collaboration with PLOS, the Drugs for Neglected Diseases initiative marks its 10-year anniversary by issuing a report exploring the lessons learned from a decade of research and development of new treatments for neglected diseases via a cost-effective, innovative, not-for-profit drug development model.

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 2-Dec-2013
Antimicrobial Agents and Chemotherapy
Scientists present groundbreaking HIV prevention research
Researchers at the Oak Crest Institute of Science are making history by proving that it's possible to develop a drug delivery system that has the potential to protect women from sexually transmitted HIV and herpes simplex virus, while at the same time preventing unintended pregnancy. The report in the journal of Antimicrobial Agents and Chemotherapy describes in vivo results from a novel, multipurpose pod-intravaginal ring delivering three antiretroviral drugs in combination with two hormonal contraceptives.

Contact: Dr. Marc M. Baum
info@oak-crest.org
626-817-0883
Oak Crest Institute of Science

Public Release: 2-Dec-2013
Proceedings of the National Academy of Sciences
Culling vampire bats to stem rabies in Latin America can backfire
Culling vampire bat colonies to stem the transmission of rabies in Latin America does little to slow the spread of the virus and could even have the reverse effect, according to University of Michigan researchers and their colleagues.
National Science Foundation, University of Georgia, Centers for Disease Control and Prevention

Contact: Jim Erickson
ericksn@umich.edu
734-647-1842
University of Michigan

Public Release: 2-Dec-2013
Blood
New report illustrates persistent global burden of anemia among high-risk populations
Despite increasing efforts to diagnose and treat anemia worldwide, there remains a surprisingly large global burden of the disease, particularly among young children and women, according to a new report on trends in anemia between 1990 and 2010.

Contact: Amanda Szabo
aszabo@hematology.org
202-552-4914
American Society of Hematology

Public Release: 2-Dec-2013
USAID awards CONRAD and Eastern Virginia Medical School funding for development of new HIV prevention
Richard V. Homan, MD, President and Provost of Eastern Virginia Medical School (EVMS) and Dean of the School of Medicine, along with Alfred Z. Abuhamad, Chair and Professor of EVMS Obstetrics and Gynecology, announced today that CONRAD, a leading reproductive health-research organization at the school, will receive up to $80 million over the course of five years from the United States President's Emergency Plan for AIDS Relief through the US Agency for International Development.
US President's Emergency Plan for AIDS Relief, US Agency for International Development

Contact: Annette Larkin
alarkin@conrad.org
703-772-6427
CONRAD

Public Release: 28-Nov-2013
Proceedings of the National Academy of Sciences
Researchers pinpoint superbug resistance protein
Researchers identified a resistance protein that allows a "superbug" to survive a disinfectant used in hospitals.
International Research Staff Exchange Scheme

Contact: c.j.bunting@leeds.ac.uk
c.j.bunting@leeds.ac.uk
0044-113-343-2049
University of Leeds

Public Release: 27-Nov-2013
Nature
Study finds vulnerability in malaria parasite
An international team of scientists, including researchers at Columbia University Medical Center, has identified a key metabolic enzyme that common malaria parasites require for survival at each stage of infection in humans. The findings raise the possibility of a new approach to combating malaria, one of the world's deadliest diseases. The study was published today in the online edition of the journal Nature.
Welcome Trust, Medicines for Malaria Venture

Contact: Karin Eskenazi
ket2116@columbia.edu
212-342-0508
Columbia University Medical Center

Public Release: 27-Nov-2013
Annals of Oncology
Global study reveals pandemic of untreated cancer pain due to over-regulation of pain medicines
A ground-breaking international collaborative survey, published in Annals of Oncology, shows that more than half of the world's population live in countries where regulations that aim to stem drug misuse leave cancer patients without access to opioid medicines for managing cancer pain.

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Public Release: 27-Nov-2013
New England Journal of Medicine
The good news about the global epidemic of dementia
As many Americans share holiday meals with family members whose memories are impaired, here's some good news about dementia, in the New England Journal, from Eric B. Larson, MD, MPH, of Group Health Research Institute; Kristine Yaffe, MD, of the University of California, San Francisco; and Kenneth M. Langa, MD, PhD, of the University of Michigan: The age-adjusted rate of cases seems to be declining worldwide with more education, prosperity, and prevention of vascular risk.

Contact: Rebecca Hughes
hughes.r@ghc.org
206-287-2055
Group Health Research Institute

Public Release: 26-Nov-2013
Antimicrobial Agents and Chemotherapy
Treatment target identified for a public health risk parasite
In the developing world, Cryptosporidium parvum has long been the scourge of freshwater. Its rapid ability to spread, combined with an incredible resilience to water decontamination techniques, such as chlorination, led the National Institutes of Health in the United Sates to add C. parvum to its list of public bioterrorism agents. Currently, there are no reliable treatments for cryptosporidiosis, but that may be about to change with the identification of a target molecule by MUHC investigators.
Sandler Foundation, Montreal General Hospital Foundation, Research Institute, McGill University Health Centre

Contact: Julie Robert
julie.robert@muhc.mcgill.ca
514-934-1934 x71381
McGill University Health Centre

Public Release: 26-Nov-2013
BUSM/BMC receives Grand Challenges Explorations grant to develop next generation condom
The department of radiology at Boston University School of Medicine and Boston Medical Center is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.
Grand Challenges Explorations

Contact: Jenny Eriksen Leary
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center

Public Release: 21-Nov-2013
Science
Study of fluke parasites identifies drug resistance mutations; raises hope for new therapies
An international group of scientists lead by Tim Anderson Ph.D., at the Texas Biomedical Research Institute and Philip LoVerde Ph.D., at the University of Texas Health Science Center at San Antonio has identified the mutations that result in drug resistance in a parasite infecting 187 million people in South America, Africa and Asia. The new finding allows detailed understanding of the drugs' mechanism of action and raises prospects of improved therapies.
National Institutes of Health, World Health Organization, Wellcome Trust

Contact: Tim Anderson
tanderso@txbiomed.org
210-748-4697
Texas Biomedical Research Institute

Public Release: 20-Nov-2013
Illinois receives Grand Challenges Explorations grants
Two Illinois professors, Daniel Rock and Mark Kuhlenschmidt, are receiving Grand Challenges Explorations grants from the Bill & Melinda Gates Foundation for research on single dose perpetual livestock vaccines and a system to study the dangerous protozoan Cryptosporidium.
Bill and Melinda Gates Foundation

Contact: Chelsey B. Coombs
diya@illinois.edu
217-333-5802
University of Illinois at Urbana-Champaign

Public Release: 20-Nov-2013
World's leading lung societies unite to call for improvements in health care
Experts from the world's leading lung organizations have come together for the first time to call for a worldwide effort to improve health-care policies and systems and care delivery to make a positive difference for the lung health of the world. Produced by the Forum of International Respiratory Societies, the report has been launched today, on World COPD Day, providing an overview of lung health across the globe.

Contact: Kristi Bruno
kbruno@chestnet.org
773-750-9962
American College of Chest Physicians

Public Release: 20-Nov-2013
PLOS ONE
Study is first to explain type of antimalarial drug resistance
This study explores why drugs designed to fight off malaria stop working in some people with the disease. Researchers found genetic and cell biological evidence linking autophagy to resistance to the parasite. Autophagy is the process by which cells remove damaged parts of themselves to restore normal function. In this case, the cell rids itself of the parts damaged by the antimalarial drug.
National Institutes of Health, Kentucky Science and Engineering Foundation

Contact: Maggie Moore
mem95@georgetown.edu
Georgetown University Medical Center

Public Release: 19-Nov-2013
Proceedings of the National Academy of Sciences
The human health costs of losing natural systems: Quantifying Earth's worth to public health
A new paper from members of the HEAL (Health & Ecosystems: Analysis of Linkages) consortium delineates a new branch of environmental health that focuses on the public health risks of human-caused changes to Earth's natural systems.

Contact: Scott Smith
ssmith@wcs.org
718-220-3698
Wildlife Conservation Society

Public Release: 19-Nov-2013
Journal of Medical Internet Research
Hashtag health
A social media–monitoring program led by San Diego State University geography professor Ming-Hsiang Tsou could help physicians and health officials learn when and where severe outbreaks are occurring in real time. In results published last month in the Journal of Medical Internet Research, Tsou demonstrated that his technique might allow officials to more quickly and efficiently direct resources to outbreak zones and better contain the spread of the disease.

Contact: Beth Chee
bchee@mail.sdsu.edu
619-594-4563
San Diego State University

Public Release: 19-Nov-2013
Nature Communications
Fruit bat population covering central Africa is carrier of 2 deadly viruses
A population of fruit bats which is found across much of continental Africa is widely infected with two deadly viruses that could spread to humans, new research reveals.

Contact: Genevieve Maul
gm349@admin.cam.ac.uk
44-012-237-65542
University of Cambridge

Public Release: 18-Nov-2013
Analytical Chemistry
SlipChip counts molecules with chemistry and a cell phone
Limited access to expensive equipment and trained professionals can impede the diagnosis and treatment of disease. Qualitative tests that provide a "yes" or "no" answer (like at-home pregnancy tests) have been optimized for resource-limited settings, but most quantitative tests -- needed to determine precise concentrations, like viral loads -- are still done in a laboratory. Using a lab-on-a-chip device and a smartphone, Caltech researchers developed a method to determine the concentration of HIV RNA in a sample.
Defense Advanced Research Projects Agency, National Institutes of Health

Contact: Deborah Williams-Hedges
mr@caltech.edu
626-395-3227
California Institute of Technology

Public Release: 18-Nov-2013
Journal of the Royal Statistical Society Series A
Control malaria by segmenting sleeping arrangements
Better malaria control might come from segregating household sleeping arrangements, according to a new study co-authored by a University of Guelph professor. The researchers found malaria eradication related more to household size than to a country's wealth or temperature. They found that when average household size drops below four persons, malaria extermination is much more likely. "When we controlled for all the variables, the factor that had the most explanatory power on malaria control was household size," said Prof. Ross McKitrick.

Contact: Ross McKitrick
rmckitri@uoguelph.ca
519-824-4120 x52532
University of Guelph

Public Release: 18-Nov-2013
Nature Communications
Bacteria use lethal cytotoxins to evade antibiotic treatment
Bacteria that cause infectious diseases produce a number of cytotoxins, and an international research team has now found the mechanism behind one of these toxins. The new results could make it possible in future to develop new treatment methods to impair the cytotoxic activity and thereby reduce the severity of infectious diseases.

Contact: Ditlev E. Brodersen
deb@mb.au.dk
45-21-66-90-01
Aarhus University

Showing releases 426-450 out of 913.

<< < 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 > >>